Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Table 2 General features of the studies included

Studies	Type of study	Patients’ enrollment period	No of patients in Rivaroxaban group (n)	No of patients in Dabigatran group (n)
Gorst 2016 [8]	Observational	2012–2014	360	1190
Larock 2014 [9]	Observational	-	35	34
Maura 2015 [10]	Observational	2012	851	1687
Providencia 2014 [11]	Observational	2012–2013	188	176
Sherid 2014 [12]	Observational	2010–2013	147	227
Total no of patients (n)			1581	3314

Study Gorst 2016 included a very large number of patients. However, the other studies consisted of less patients. Therefore, in order for the result of this analysis not to be influenced by the result of study Gorst 2016, only patients with diabetes mellitus were selected from that particular study

ISSN: 1471-2261